English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
Singapore Institutes Collaborate with Samsung Medical Center to Improve Treatment of Liver Cancer
Dec 14, 2017 10:00 HKT
Nanobiotix presented new clinical and pre-clinical data confirming NBTXR3's significant potential role in Immuno-Oncology at SITC Annual Meeting
Nov 13, 2017 15:00 HKT
Nanobiotix provides update on the global development of its lead product NBTXR3
Nov 10, 2017 08:30 HKT
Singapore eDevelopment's Global BioLife confirms 100% Repellency of 3F Mosquito Fragrance
Nov 01, 2017 18:00 HKT
Singapore eDevelopment's Global BioLife develops Low-GI Modified Sugar
Oct 24, 2017 18:00 HKT
Nanobiotix Completes Patient Inclusion for Phase II/III Trial of NBTXR3 in Soft Tissue Sarcoma
Oct 23, 2017 14:00 HKT
ASX-Listed Holista and Holista Foods Inc. (USA) Develop Breakthrough Noodle Formula with Low-Glycemic Score of 38
Oct 19, 2017 16:00 HKT
Helsinn Pharmaceuticals (Beijing) Co. Ltd. Opens Office in Shanghai, China
Oct 17, 2017 14:30 HKT
Sanofi: Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent(R) (alirocumab)
Oct 06, 2017 08:00 HKT
Nanobiotix plans to conduct its first clinical trial with NBTXR3 in combination with immune checkpoint inhibitors in the U.S.
Sep 29, 2017 08:00 HKT
Nanobiotix half year results for the six months ended 30 June 2017
Sep 01, 2017 01:30 HKT
Kingworld Medicines 1H2017 Profit Up10.1% to RMB22.1 Million; EPS Surges 20%
Aug 30, 2017 13:04 HKT
NANOBIOTIX: New Translational Data Presented at ASTRO, NCI and SITC's Immunotherapy Workshop
Jun 16, 2017 06:00 HKT
Clinical Validation Results confirm PromarkerD can predict Diabetic Kidney Disease better than any Current Measure
Jun 12, 2017 08:00 HKT
Human Heart Tissue Grown from Stem Cells Improves Drug Testing
Jun 08, 2017 10:00 HKT
NANOBIOTIX: Promising Data from Phase I/II Head and Neck Cancer Trial with NBTXR3 Presented at the American Society of Clinical Oncology's Annual Meeting
Jun 06, 2017 00:00 HKT
Research jointly led by HKBU and HKUST decoding the first deep-sea mussel genome published in Nature Ecology & Evolution
May 23, 2017 23:30 HKT
Singapore eDevelopment Subsidiary Initiates Research on New Universal Drug Platform
May 22, 2017 11:00 HKT
Microbiome leader Professor Borody calls for a National Australian FMT Bank to fight Drug Resistant Diseases
May 19, 2017 06:00 HKT
HKBU Chinese Medicine Scholars Conduct Research in Space Life Science aboard China's Tianzhou 1
May 18, 2017 19:00 HKT
<< Previous  Next >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: